Plant Polysaccharides Modulate Immune Function via the Gut Microbiome and May Have Potential in COVID-19 Therapy

Molecules. 2022 Apr 26;27(9):2773. doi: 10.3390/molecules27092773.

Abstract

Plant polysaccharides can increase the number and variety of beneficial bacteria in the gut and produce a variety of active substances, including short-chain fatty acids (SCFAs). Gut microbes and their specific metabolites have the effects of promoting anti-inflammatory activity, enhancing the intestinal barrier, and activating and regulating immune cells, which are beneficial for improving immunity. A strong immune system reduces inflammation caused by external viruses and other pathogens. Coronavirus disease 2019 (COVID-19) is still spreading globally, and patients with COVID-19 often have intestinal disease and weakened immune systems. This article mainly evaluates how polysaccharides in plants can improve the immune system barrier by improving the intestinal microecological balance, which may have potential in the prevention and treatment of COVID-19.

Keywords: COVID-19; SCFAs; gut flora; immunity; plant polysaccharides; probiotics.

Publication types

  • Review

MeSH terms

  • COVID-19 Drug Treatment*
  • Fatty Acids, Volatile / metabolism
  • Gastrointestinal Microbiome*
  • Humans
  • Immunity
  • Polysaccharides / metabolism
  • Polysaccharides / pharmacology
  • Polysaccharides / therapeutic use

Substances

  • Fatty Acids, Volatile
  • Polysaccharides